Document Detail

Infectious complications associated with immunomodulating biologic agents.
MedLine Citation:
PMID:  20466271     Owner:  NLM     Status:  MEDLINE    
The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.
Sophia Koo; Francisco M Marty; Lindsey R Baden
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Infectious disease clinics of North America     Volume:  24     ISSN:  1557-9824     ISO Abbreviation:  Infect. Dis. Clin. North Am.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-14     Completed Date:  2010-08-09     Revised Date:  2011-02-07    
Medline Journal Info:
Nlm Unique ID:  8804508     Medline TA:  Infect Dis Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  285-306     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / adverse effects*,  therapeutic use*
Communicable Diseases / epidemiology*
Immunologic Factors / adverse effects*,  therapeutic use*
United States
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunologic Factors
Republished in:
Hematol Oncol Clin North Am. 2011 Feb;25(1):117-38   [PMID:  21236394 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Infection in organ transplantation: risk factors and evolving patterns of infection.
Next Document:  Infections in pediatric transplant recipients: not just small adults.